GI Oncology
News
Stage esophageal cancer after neoadjuvant chemo
Key clinical point: Tumor stage after completion of neoadjuvant chemotherapy is a much more important predictor of survival than is initial tumor...
News
TCGA investigators propose four subtypes of gastric cancer
News
Everolimus fails to improve HCC survival
Key clinical point: Despite the "strong scientific rationale and preclinical data," everolimus failed to improve outcomes in advanced HCC. Major...
News
Genetic marker for better colon cancer prognosis halved among African Americans
Key clinical point: Racial disparity in colon cancer mortality may be due in part to biological differences in tumor type.Major finding: The...
News
Vaccine-chemo combination boosts immunotherapy in pancreatic cancer
Key clinical point: A therapeutic vaccine combined with low-dose chemotherapy converted pancreatic ductal adenocarcinomas into immunogenic cancers...
News
Pancreatic cancer predicted to become second-leading cause of U.S. cancer deaths by 2030
Major finding: In the United States, pancreatic and liver cancers are projected to overtake breast, prostate, and colorectal cancers to become the...
News
Angiogenesis inhibitor approved for advanced gastric cancer
News
Few eligible patients undergo radical cholecystectomy
News
Physician’s adenoma detection rate predicts patient’s cancer risk
Major finding: For patients of physicians with adenoma detection rates in the highest quintile (33.51%-52.51%), compared with those of physicians...
News
Interval CRC may be distinct pathology
Major finding: Up to 6% of colorectal cancers may not be detected until within 6-60 months of an index colonoscopy.Data source: A population-based...
News
Better survival with aspirin in HLA class 1 antigen-positive cancers only
Major finding: Overall survival was significantly longer among aspirin users whose tumors expressed HLA class I antigen, with a RR of 0.53,...